谷歌浏览器插件
订阅小程序
在清言上使用

A phase 3 study of Ravulizumab (ALXN1210) vs. Eculizumab in adults with paroxysmal nocturnal hemoglobinuria currently treated with Eculizumab: subgroup analysis by transfusion history and demographics

ONCOLOGY RESEARCH AND TREATMENT(2019)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要